Liposome encapsulated epirubicinAlternative Names: Electrostatic liposome encapsulated epirubicin; LEE
Latest Information Update: 19 Oct 2016
At a glance
- Originator NeoPharm Inc
- Class Cytostatic antibiotics; Doxorubicins
- Mechanism of Action DNA intercalators; RNA synthesis inhibitors; Type II DNA topoisomerase inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Breast cancer
Most Recent Events
- 27 Nov 2001 Preclinical development for Breast cancer in USA (unspecified route)